Clinical TrialsSearch results
Number of results: 750
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Effect of nitric oxide synthase (NOS) activity on Lenvatinib for unresectable hepatocellular carcinoma
- Unresectable hepatocellular carcinoma
- Hidaka Hisashi
- 2021-08-27
Other
- Phase I/II study of hepatic arterial infusion chemotherapy of gemcitabine for unresectable cholangiocarcinoma (JIVROSG-0301)
- Unresectable cholangiocarcinoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-07
Completed
- Estimation of the Prevalence of HER2 Low and Describe the SoC, Treatment Patterns, and Outcome in Real-world Practice Among Unresectable and/or Metastatic Breast Cancer Patients With HER2 Low Status
- Unresectable and/or Metastatic Breast Cancer
- Fujiwara Kosaku
- 2021-08-18
Other
- Phase II study of Bevacizumab plus modified OPTIMOX1 in patients with unresectable advanced/recurrent colorectal cancer
- Unresectable advanced/recurrent colorectal cancer
- The Tokyo Cooperative Oncology Group
- 2008-06-01
Other
- Phase2/3 Study of OTS102 in Combination With Gemcitabine in Patients With Unresectable Advanced Pancreatic Cancer and Recurrent Pancreatic Cancer(PEGASUS-PC Study)
- Unresectable Advanced and Recurrent Pancreatic Cancer
- OncoTherapy Science, Inc.
- 2009-01-27
Other
- Early Phase II clinical trial of PC-SOD
-Study of the efficacy and safety of PC-SOD in patients with ulcerative colitis-
- Ulcerative colitis(UC-DAI:more than 4)
- LTT Bio-Pharma Co.,Ltd.
- 2007-06-27
Other
- Establishment of surveillance system for the longstanding ulcerative colitis patients
Comparative study of efficacy for the targeted biopsy and the step biopsy
- Ulcerative colitis
- Teikyo University School of Medicine
- 2009-01-05
Completed
- Alternation in glucagon secretion by Sodium glucose transporter-2 inhibitor
- Type2 diabetes mellitus
- Ichikawa Raishi
- 2019-04-16
Other
- Clinical study of combinational therapy of AD-4833 with metformin
-Phase III double-blind comparative study-
- Type2 Diabetes
- Takeda Pharmaceutical Company Limited
- 2008-04-04
Other
- Post-marketing Clinical Trial of Pioglitazone - A Study of Preventive Effects on the Onset and Recurrence of Macrovascular Events -
- Type2 Diabetes
- Takeda Pharmaceutical Company Limited
- 2008-09-10